Nonallergic Rhinitis Market Research Report - Forecast till 2027

Nonallergic Rhinitis Market Share, Growth And Trends Analysis By Diagnosis (Physical Examination, Allergy Testing, And Imaging Test), Treatment (Nasal Sprays, Nsaids), End User (Hospitals &, Clinics, Research Centers) - Forecast Till 2027

ID: MRFR/Pharma/3701-HCR | | Region: Global | 110 pages

Nonallergic Rhinitis Market Overview


 Also known as vasomotor rhinitis, nonallergic rhinitis is a medical condition that causes chronic sneezing, and congestion. Although the symptoms of nonallergic rhinitis are similar to that of allergic rhinitis, it does not involve the immune system. This condition can be diagnosed with, physical examination, allergy test such as skin test, blood test, and imaging tests such as CT scan. Treatment includes use of nasal sprays, oral decongestants, and over-the-counter (OTC) drugs or prescription medications.


Rising prevalence of nonallergic rhinitis, and increasing demand for diagnosis and treatment of nonallergic rhinitis are the major factors driving the growth of the nonallergic rhinitis market across the globe. Furthermore, increasing healthcare expenditure and overall growth of healthcare industry also influences the nonallergic rhinitis market growth. Splendid research in the field of immunology also boost the nonallergic rhinitis market. Additionally, increasing focus on the development of new medications for the treatment of nonallergic rhinitis, and increasing use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) also fuel the market growth. The growth of the market is restricted by increasing competition among key players in the nonallergic rhinitis market that act as a barrier of new entrants.


The nonallergic rhinitis market is expected to grow at a CAGR of 5.3% during the forecast period.


Segments


The global nonallergic rhinitis market is segmented on the basis of diagnosis, treatment, and end user.


On the basis of diagnosis, nonallergic rhinitis market is categorized into physical examination, allergy testing, imaging test, and other segments. Allergy testing is further segmented into skin test and blood test. Imaging test is further segmented into nasal endoscopy, and computerized tomography (CT) Scan.


On the basis of treatment, the nonallergic rhinitis market is segmented into nasal sprays, NSAIDs and others.


Nasal sprays is further segmented into saline, corticosteroid, antihistamine, decongestants, and anti-drip anticholinergic.


On the basis of end user, the nonallergic rhinitis market is segmented into hospitals & clinics, research centers, and others.

FIGURE 1: Global Nonallergic Rhinitis Market by Region, 2016 (%)
Nonallergic Rhinitis Market


Source: World Health Organization, Centers for Disease Control and Prevention, U.S. National Library of Medicine, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Intended Audience



  • Medical Device Manufacturers

  • Medical Device Suppliers

  • Medical Research Laboratories

  • Healthcare IT Companies

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


Regional Analysis of the Nonallergic Rhinitis Market               


America holds the first position in the nonallergic rhinitis market owing to the rising prevalence of nonallergic rhinitis in the U.S., and consequent increase in the demand for new diagnostic and treatment services. In Americas, North America is the largest market owing to the presence of key players in the industry. As per the Warren Alpert Medical School of Brown University, the prevalence of nonallergic rhinitis has been observed to be one-third that of allergic rhinitis, affecting ~7% of the U.S. population or ~22 million people. Additionally, rising awareness about morbidity due to nonallergic rhinitis and the presence of key players in the market also influence the growth of the market.


Europe is the second largest market for nonallergic rhinitis. In Europe, there is an increasing demand for nasal sprays, and extensive research and development activities by clinical research and academic institutes for chronic diseases treatment. Germany, and France are the largest contributors to the market growth owing to an increase in the number of market players manufacturing NSAIDs, and overall growth of healthcare industry.


The market in Asia Pacific is expected to grow at the fastest pace and is driven by an increasing number of patients suffering from nonallergic rhinitis and increasing awareness about the diagnosis and treatment. India, China, and Japan are major contributors to the growth of the market. This growth is attributed to an increasing demand for nasal sprays and OTC medicines and availability of highly qualified medical personnel dedicated to the research of chronic diseases.


The Middle East & Africa also show a steady rise in the market owing to low prevalence of nonallergic rhinitis and increasing awareness about allergic and nonallergic rhinitis treatment. In the Middle East & Africa, the Middle East captures the largest market share for availability of specialty medical services and increasing expenditure on healthcare

Research Methodology
Nonallergic Rhinitis Market 2018


Key Players in the Nonallergic Rhinitis Market 


Some of the key players in nonallergic rhinitis market are Boehringer Ingelheim GmbH (Germany), Novartis (U.S.), GlaxoSmithKline (U.K), Perrigo Company plc (Ireland), Johnson & Johnson Consumer Inc. (U.S.), Bayer (U.S.), Sanofi (France) and others.



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   5.3% (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Diagnosis, Treatment, and End user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Boehringer Ingelheim GmbH (Germany), Novartis (U.S.), GlaxoSmithKline (U.K), Perrigo Company plc (Ireland), Johnson & Johnson Consumer Inc. (U.S.), Bayer (U.S.), Sanofi (France) and others
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Rising prevalence of nonallergic rhinitis
  • Increasing demand for diagnosis and treatment of nonallergic rhinitis


  • Frequently Asked Questions (FAQ) :


    Nonallergic rhinitis market is expected to exhibit a CAGR of 5.3% from 2017 to 2023.

    Rising number of cases of nonallergic rhinitis and demand for its effective treatment are major drivers of the global nonallergic rhinitis market.

    Increasing competition among players can hamper the global nonallergic rhinitis market.

    The Americas can dominate the global nonallergic rhinitis market till 2023.

    Bayer, GlaxoSmithKline, Sanofi, Boehringer Ingelheim GmbH, Perrigo Company plc, Johnson & Johnson Consumer Inc., and Novartis are notable players of the global nonallergic rhinitis market.

    Table of Content

    1. Report Prologue

    2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary research

    3.4 Market Size Estimation

    4. Market Dynamics

    4.1 Drivers

    4.2 Restrains

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    5. Market Factor Analysis

    5.1 Porters Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    6. Global Nonallergic Rhinitis Market, by Diagnosis

    6.1 Introduction

    6.2 Physical Examination

    6.2.1 Market Estimates & Forecast, 2020-2027

    6.3 Allergy Testing

    6.3.1 Market Estimates & Forecast, 2020-2027

    6.4 Imaging Test

    6.4.1 Market Estimates & Forecast, 2020-2027

    6.5 Others

    6.5.1 Market Estimates & Forecast, 2020-2027

    7. Global Nonallergic Rhinitis Market, by Treatment

    7.1 Introduction

    7.2 Nasal Sprays

    7.2.1 Market Estimates & Forecast, 2020-2027

    7.3 NSAIDs

    7.3.1 Market Estimates & Forecast, 2020-2027

    7.4 Others

    7.4.1 Market Estimates & Forecast, 2020-2027

    8. Global Nonallergic Rhinitis Market, by End User

    8.1 Introduction

    8.2 Hospitals & Clinics

    8.2.1 Market Estimates & Forecast, 2020-2027

    8.3 Research Centers

    8.3.1 Market Estimates & Forecast, 2020-2027

    8.4 Others

    8.4.1 Market Estimates & Forecast, 2020-2027

    9. Global Nonallergic Rhinitis Market, by Region

    9.1 Introduction

    9.2 Americas

    9.2.1 North America

    9.2.1.1 U.S.

    9.2.1.1 Canada

    9.2.2 South America

    9.3 Europe

    9.3.1 Western Europe

    9.3.1.1 Germany

    9.3.1.2 France

    9.3.1.3 U.K.

    9.3.1.4 Italy

    9.3.1.5 Spain

    9.3.1.6 Rest of Western Europe

    9.3.2 Eastern Europe

    9.4 Asia Pacific

    9.4.1 Japan

    9.4.2 China

    9.4.3 India

    9.4.4 Australia

    9.4.5 Republic of Korea

    9.4.6 Rest of Asia Pacific

    9.5 The Middle East & Africa

    9.5.1 United Arab Emirates

    9.5.2 Saudi Arabia

    9.5.3 Oman

    9.5.4 Kuwait

    9.5.5 Qatar

    9.5.6 Rest of the Middle East & Africa

    10 Company Landscape

    10.1 Introduction

    10.2 Market Share Analysis

    10.3 Key Development & Strategies

    10.3.1 Key Developments

    11 Company Profiles

    11.1 Boehringer Ingelheim GmbH

    11.1.1 Company Overview

    11.1.2 Product Overview

    11.1.3 Financials

    11.2 Novartis

    11.2.1 Company Overview

    11.2.2 Product Overview

    11.2.3 Financial Overview

    11.2.4 Key Developments

    11.3 GlaxoSmithKline plc.

    11.3.1 Company Overview

    11.3.2 Product Overview

    11.3.3 Financial Overview

    11.3.4 Key Development

    11.4 Johnson & Johnson Consumer Inc.

    11.4.1 Company Overview

    11.4.2 Product/Business Segment Overview

    11.4.3 Financial Overview

    11.4.4 Key Development

    11.5 Bayer

    11.5.1 Company Overview

    11.5.2 Product Overview

    11.5.3 Financial overview

    11.5.4 Key Developments

    11.6 Sanofi

    11.6.1 Company Overview

    11.6.2 Product Overview

    11.6.3 Financial Overview

    11.6.4 Key Developments

    11.7 Perrigo Company plc

    11.7.1 Overview

    11.7.2 Product Overview

    11.7.3 Financials

    11.7.4 Key Developments

    11.8 Others

    12 MRFR Conclusion

    12.1 Key Findings

    12.1.1 From CEO’s View Point

    12.1.2 Unmet Needs of the Market

    12.2 Key Companies to Watch

    12.3 Prediction of Industry

    13 Appendix

    LIST OF TABLES

    Table 1 Nonallergic Rhinitis Industry Synopsis, 2020-2027

    Table 2 Global Nonallergic Rhinitis Market Estimates and Forecast, 2020-2027, (USD Million)

    Table 3 Global Nonallergic Rhinitis Market by Region, 2020-2027, (USD Million)

    Table 4 Global Nonallergic Rhinitis Market by Diagnosis, 2020-2027, (USD Million)

    Table 5 Global Nonallergic Rhinitis Market by Treatment, 2020-2027, (USD Million)

    Table 6 Global Nonallergic Rhinitis Market by End Users, 2020-2027, (USD Million)

    Table 7 North America Nonallergic Rhinitis Market by Diagnosis, 2020-2027, (USD Million)

    Table 8 North America Nonallergic Rhinitis Market by Treatment, 2020-2027, (USD Million)

    Table 9 North America Nonallergic Rhinitis Market by End Users, 2020-2027, (USD Million)

    Table 10 U.S. Nonallergic Rhinitis Market by Diagnosis, 2020-2027, (USD Million)

    Table 11 US Nonallergic Rhinitis Market by Treatment, 2020-2027, (USD Million)

    Table 12 US Nonallergic Rhinitis Market by End Users, 2020-2027, (USD Million)

    Table 13 Canada Nonallergic Rhinitis Market by Diagnosis, 2020-2027, (USD Million)

    Table 14 Canada Nonallergic Rhinitis Market by Treatment, 2020-2027, (USD Million)

    Table 15 Canada Nonallergic Rhinitis Market by End Users, 2020-2027, (USD Million)

    Table 16 South America Nonallergic Rhinitis Market by Diagnosis, 2020-2027, (USD Million)

    Table 17 South America Nonallergic Rhinitis Market by Treatment, 2020-2027, (USD Million)

    Table 18 South America Nonallergic Rhinitis Market by End Users, 2020-2027, (USD Million)

    Table 19 Europe Nonallergic Rhinitis Market by Diagnosis, 2020-2027, (USD Million)

    Table 20 Europe Nonallergic Rhinitis Market by Treatment, 2020-2027, (USD Million)

    Table 21 Europe Nonallergic Rhinitis Market by End Users, 2020-2027, (USD Million)

    Table 22 Western Europe Nonallergic Rhinitis Market by Diagnosis, 2020-2027, (USD Million)

    Table 23 Western Europe Nonallergic Rhinitis Market by Treatment, 2020-2027, (USD Million)

    Table 24 Western Europe Nonallergic Rhinitis Market by End Users, 2020-2027, (USD Million)

    Table 25 Eastern Europe Nonallergic Rhinitis Market by Diagnosis, 2020-2027, (USD Million)

    Table 26 Eastern Europe Nonallergic Rhinitis Market by Treatment, 2020-2027, (USD Million)

    Table 27 Eastern Europe Nonallergic Rhinitis Market by End Users, 2020-2027, (USD Million)

    Table 28 Asia Pacific Nonallergic Rhinitis Market by Diagnosis, 2020-2027, (USD Million)

    Table 29 Asia Pacific Nonallergic Rhinitis Market by Treatment, 2020-2027, (USD Million)

    Table 30 Asia Pacific Nonallergic Rhinitis Market by End Users, 2020-2027, (USD Million)

    Table 31 Middle East & Africa Nonallergic Rhinitis Market by Diagnosis, 2020-2027, (USD Million)

    Table 32 Middle East & Africa Nonallergic Rhinitis Market by Treatment, 2020-2027, (USD Million)

    Table 33 Middle East & Africa Nonallergic Rhinitis Market by End Users, 2020-2027, (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Nonallergic Rhinitis Market

    Figure 3 Segmentation Market Dynamics for Nonallergic Rhinitis Market

    Figure 4 Global Nonallergic Rhinitis Market Share, by Diagnosis 2020

    Figure 5 Global Nonallergic Rhinitis Market Share, by Treatment 2020

    Figure 6 Global Nonallergic Rhinitis Market Share, by End Users, 2020

    Figure 7 Global Nonallergic Rhinitis Market Share, by Region, 2020

    Figure 8 North America Nonallergic Rhinitis Market Share, by Country, 2020

    Figure 9 Europe Nonallergic Rhinitis Market Share, by Country, 2020

    Figure 10 Asia Pacific Nonallergic Rhinitis Market Share, by Country, 2020

    Figure 11 Middle East & Africa Nonallergic Rhinitis Market Share, by Country, 2020

    Figure 12 Global Nonallergic Rhinitis Market: Company Share Analysis, 2020 (%)

    Figure 13 Boehringer Ingelheim GmbH: Key Financials

    Figure 14 Boehringer Ingelheim GmbH: Segmental Revenue

    Figure 16 Boehringer Ingelheim GmbH: Geographical Revenue

    Figure 17 Novartis: Key Financials

    Figure 18 Novartis: Segmental Revenue

    Figure 19 Novartis: Geographical Revenue

    Figure 20 GlaxoSmithKline plc: Key Financials

    Figure 21 GlaxoSmithKline plc: Segmental Revenue

    Figure 22 GlaxoSmithKline plc: Geographical Revenue

    Figure 23 Bayer: Key Financials

    Figure 24 Bayer: Segmental Revenue

    Figure 25 Bayer: Geographical Revenue

    Figure 26 Bayer: Key Financials

    Figure 27 Perrigo Company plc: Segmental Revenue

    Figure 28 Perrigo Company plc: Geographical Revenue

    Figure 29 Perrigo Company plc: Key Financials

    Figure 30 Sanofi: Segmental Revenue

    Figure 31 Sanofi: Geographical Revenue

    Figure 32 Sanofi.: Key Financials